Please assess the completion status of the following clinical trial:

Trial Title: Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. All patients with acute hepatic insult manifesting as jaundice (Sr. Bil. ≥ 5 mg/dL) and coagulopathy (INR≥1.5), complicated within 4 weeks by ascites and/or encephalopathy in a patient with previously diagnosed or undiagnosed chronic liver disease (ACLF) admitted in the hospital.~2. All Cirrhotics decompensated with ascites admitted in the hospital.~3. Grade II/III ascites~4. Need for paracentesis.~Exclusion Criteria:~1. Age \<12 or \> 75 years~2. Hepatocellular carcinoma~3. Non cirrhotic ascites such as malignancy or tubercular peritonitis~4. Serum Cr \>1.5mg%~5. Refractory septic shock~6. Grade III/IV hepatic encephalopathy~7. Abdominal wall cellulitis~8. Active variceal bleed~9. Respiratory, cardiac and renal failure~10. Refusal to participate in the study

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Albumin (Type: EXPERIMENTAL): MVP (Modest Volume Paracentesis) of less than 5 litres with intravenous albumin at a dose 8 gms/l of ascitic fluid.
- No Albumin (Type: ACTIVE_COMPARATOR): MVP (Modest Volume Paracentesis) of less than 5 litres without albumin.

Based on this trial design, predict the completion outcome and termination type (if applicable).